KY-62, a polyene analog of amphotericin B, for treatment of murine candidiasis - Wikidata - awgldk - TriplyDB

KY-62, a polyene analog of amphotericin B, for treatment of murine candidiasis

KY-62, a polyene analog of amphotericin B, for treatment of murine candidiasis

http://www.wikidata.org/entity/Q28379319

about

Efficacies of KY62 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous leishmaniasis and visceral leishmaniasis Characterization of a Polyethylene Glycol-Amphotericin B Conjugate Loaded with Free AMB for Improved Antifungal Efficacy.

P2860

Q33698601-CEB0B927-070E-474D-A770-01EDB0518FA2 Q35967724-6E81C91F-4227-43C8-B641-8749918F793A

P2860

KY-62, a polyene analog of amphotericin B, for treatment of murine candidiasis

http://www.wikidata.org/entity/Q28379319

description

1998 nî lūn-bûn

@nan

1998 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

KY-62, a polyene analog of amphotericin B, for treatment of murine candidiasis

@ast

KY-62, a polyene analog of amphotericin B, for treatment of murine candidiasis

@en

KY-62, a polyene analog of amphotericin B, for treatment of murine candidiasis

@nl

type

label

KY-62, a polyene analog of amphotericin B, for treatment of murine candidiasis

@ast

KY-62, a polyene analog of amphotericin B, for treatment of murine candidiasis

@en

KY-62, a polyene analog of amphotericin B, for treatment of murine candidiasis

@nl

prefLabel

KY-62, a polyene analog of amphotericin B, for treatment of murine candidiasis

@ast

KY-62, a polyene analog of amphotericin B, for treatment of murine candidiasis

@en

KY-62, a polyene analog of amphotericin B, for treatment of murine candidiasis

@nl

P1433

Q28379319-80C5C7A5-F9FB-484E-94C9-479E499ECEFF

P1476

Q28379319-DE50EC13-7F5B-478A-A6AC-0C88476F5111

P2093

Q28379319-068B9F4B-41D0-43E9-B567-1F736DDF8B67

Q28379319-5621B21B-212D-419A-8462-63DCB8FAC30F

Q28379319-8828822C-57F6-4680-BCCA-C882A90F38D1

Q28379319-B44324AC-5F29-4DFE-8D1A-7BAFEC3554EE

Q28379319-F2D43A7A-D34E-4653-B606-ACC52E98559A

Q28379319-F6BA1CF5-AD66-4EEB-952C-D6F11E394AF5

Q28379319-FEFB076B-617B-4C5B-B082-8F39B689446D

P2860

Q28379319-0223E45D-F6CB-4FC1-B10D-4FD85037C4A2

Q28379319-590934EB-3423-4D4A-A9BA-4DAA9580BBB9

Q28379319-5951CEA0-1711-4091-8C58-286BF590F7DB

Q28379319-60095864-813E-4863-A86A-354F5F285B99

Q28379319-69771FEF-514D-44CA-B976-0E03C39A8A92

Q28379319-6BF7F7E7-2C5B-45F9-931C-DC440AD59474

Q28379319-6C1EA5AF-520D-402A-A86D-11BB378D4E3C

Q28379319-6DDDE22B-4DE8-4A51-9CCE-6C6EC27953E3

Q28379319-72EE2360-BBDD-432E-8CB5-0D13F2028448

Q28379319-7D668ED5-36C8-455F-BD1F-10359E286379

P304

Q28379319-0FE3BE14-089D-4D29-8CFC-97F576494E19

P31

Q28379319-3AAC7A42-874B-43D4-9860-89F9CF5F52FB

P3181

Q28379319-009E7C20-1488-4A0C-AD62-870C09B156BE

P356

Q28379319-44A50134-A2E5-4F6C-A625-964A46BC9E72

P407

Q28379319-A62826DD-295B-4E76-A022-A198ECABDED7

P433

Q28379319-3A65AF9C-9E40-498F-A2CB-EEA9EAEC4376

P478

Q28379319-5BD09B22-1F92-4270-9D9B-0054330F27EC

P577

Q28379319-E455F9A5-E059-478B-82CC-8E94A25D2E3A

P698

Q28379319-4418AE83-9799-4358-AB32-50240347E7C2

P932

Q28379319-D80D5359-FFB7-4AC4-A488-8779AC996E82

P3181

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

KY-62, a polyene analog of amphotericin B, for treatment of murine candidiasis

@en

P2093

A Fothergill

http://www.w3.org/2001/XMLSchema#string

C Lambros

http://www.w3.org/2001/XMLSchema#string

J R Graybill

http://www.w3.org/2001/XMLSchema#string

L K Najvar

http://www.w3.org/2001/XMLSchema#string

M Rinaldi

http://www.w3.org/2001/XMLSchema#string

S L Regen

http://www.w3.org/2001/XMLSchema#string

T Hardin

http://www.w3.org/2001/XMLSchema#string

P2860

Influence of extracellular K+ or Mg2+ on the stages of the antifungal effects of amphotericin B and filipin.

The endocytic process in CHO cells, a toxic pathway of the polyene antibiotic amphotericin B.

Tumor necrosis factor alpha has a protective role in a murine model of systemic candidiasis

Anticryptococcal effect of amphotericin B is mediated through macrophage production of nitric oxide.

Study of the effects of liposomal amphotericin B on Candida albicans, Cryptococcus neoformans, and erythrocytes by using small unilamellar vesicles prepared from saturated phospholipids.

Amphotericin B: current understanding of mechanisms of action.

Liposomal and lipid formulations of amphotericin B. Clinical pharmacokinetics.

Comparative toxicities of amphotericin B and its monomethyl ester derivative on glial cells in culture

Clinical use of amphotericin B and derivatives: lore, mystique, and fact.

Interaction of chemotherapy and immune defenses in experimental murine cryptococcosis.

P304

147-150

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

5087540

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/AAC.42.1.147

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

1998-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9449275

http://www.w3.org/2001/XMLSchema#string

P932

105470

http://www.w3.org/2001/XMLSchema#string